The CEO of Moderna, Stephane Bancel, reportedly sold 9,000 shares of Moderna stock on Wednesday, 9 February 2022, which were sold at an average price of $154.26 for a total value of $1,388,340.00, according to the SEC website's legal filing. Moreover, many Twitter users noticed that Stephane deleted his Twitter account without any notice or explanation, so many claimed that the reason for his action might be due to reports about the coronavirus vaccines.
His Twitter account was @sbancel, and when we search that username in Twitter, it says that the account no longer exists, which means it has been deleted. It is confirmed that the account belonged to the CEO, Stephane, as Moderna's official Twitter account had tagged @sbancel, referring to Stephane back in November 2021.
The tweet was about congratulating Stephane for winning the Strategist Prize 2020, and it said, "Congratulations to our CEO, @sbancel, for being awarded the Strategist Prize 2020 by @LesEchos for leading Moderna's #COVID19 vaccine strategy, deemed as the most relevant industrial strategy of the past year."
Congratulations to our CEO, @sbancel, for being awarded the Strategist Prize 2020 by @LesEchos for leading Moderna's #COVID19 vaccine strategy, deemed as the most relevant industrial strategy of the past year. pic.twitter.com/g4iNh5SQwM
— Moderna (@moderna_tx) November 15, 2021
According to Internet Archive, his account had a profile picture of himself and had 4,377 tweets, 6,396 followers, and was following 16 people at the time, and his bio read, "Moderna CEO. Like & RTs are not endorsements." It also showed that Bancel was not active on Twitter since April 2019, and he probably deleted his account on11 February, as the occasional archives showed.
Net Worth Of Stephane Bancel
Stephane Bancel has a real-time net worth of $5.2 Billion according to Forbes, as he is the CEO of Moderna, founded in 2011, and has a roughly 8% stake in the publicly-traded company. Stephane worked as the CEO of French diagnostics company BioMerieux which was founded by Alain Merieux, a fellow French billionaire.
According to a proxy filing, Stephane collected a salary of $950,000, a $1.9 million bonus, and stock options worth $9 million in 2020. Moderna's chairman Noubar Afeyan, board member Robert Langer and co-founder and early investor Timothy Springer debuted in the Forbes List of America's richest during the pandemic. Stephane Bancel made headlines back in 2020 when he sold $1.74 million worth of shares after Pfizer and BioNTech became the first companies to complete a submission for a vaccine to US regulators.
Stephane Bancel left his work as CEO of bioMerieux in 2011 and joined Moderna, and under his leadership, the company grew exponentially. He has earned numerous awards and recognitions from more than 25 years long career. He was named the Ernst & Young 2017 New England Entrepreneur of the Year, a Young Global Leader by the World Economica Forum in 2009, and Best CEO for Investor Relations in France in 2009.
Stephane had completed his chemical engineering degree from the University of Minnesota and joined Harvard Business School in the late 1990s, where he became proficient at running a multinational business. He graduated from Harvard Business School with a Master of Business Administration in 2000. He was involved in a webinar event co-sponsored by the Harvard Business Club, where he talked about the future challenges and discussed the extraordinary journey of his professional career. He had also participated in Harvard's The Other Side series in the past.
Is Stephane Bancel Married?
Stephane Bancel has been married to his wife Brenda for years, and they have two kids together. He is known to consult his business plans with his wife and has a huge net gap with her.
Stephane had shared that he told his wife his new job only had a 5 percent chance of working out when he left his job as CEO in a French medical diagnostics firm back in 2011. However, today he has become a billionaire and has sold Covid-19 vaccines. But at that time, his job was to run Moderna, which was a start-up using experimental and unproven technology. Stephane recalled how it seemed nuts at the time.